Hubbry Logo
Self-medicationSelf-medicationMain
Open search
Self-medication
Community hub
Self-medication
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Self-medication
Self-medication
Self-medication
View on Wikipedia
from Wikipedia

Self-medication, sometimes called do-it-yourself (DIY) medicine, is a human behavior in which an individual uses a substance or any exogenous influence to self-administer treatment for physical or psychological conditions, for example headaches or fatigue.

The substances most widely used in self-medication are over-the-counter drugs and dietary supplements, which are used to treat common health issues at home. These do not require a doctor's prescription to obtain and, in some countries, are available in supermarkets and convenience stores.[1]

The field of psychology surrounding the use of psychoactive drugs is often specifically in relation to the use of recreational drugs, alcohol, comfort food, and other forms of behavior to alleviate symptoms of mental distress, stress and anxiety,[2] including mental illnesses or psychological trauma.[3][4] Such treatment may cause serious detriment to physical and mental health if motivated by addictive mechanisms.[5] In postsecondary (university and college) students, self-medication with "study drugs" such as Adderall, Ritalin, and Concerta has been widely reported and discussed in literature.[5]

Products are marketed by manufacturers as useful for self-medication, sometimes on the basis of questionable evidence. Claims that nicotine has medicinal value have been used to market cigarettes as self-administered medicines. These claims have been criticized as inaccurate by independent researchers.[6][7] Unverified and unregulated third-party health claims are used to market dietary supplements.[8]

Self-medication is often seen as gaining personal independence from established medicine,[9] and it can be seen as a human right, implicit in, or closely related to the right to refuse professional medical treatment.[10] Self-medication can cause unintentional self-harm.[11] Self-medication with antibiotics has been identified as one of the primary reasons for the evolution of antimicrobial resistance.[12]

Sometimes self-medication or DIY medicine occurs because patients disagree with a doctor's interpretation of their condition,[13] to access experimental therapies that are not available to the public,[14][15] or because of legal bans on healthcare, as in the case of some transgender people[16] or women seeking self-induced abortion.[17] Other reasons for relying on DIY medical care is to avoid health care prices in the United States[18] and anarchist beliefs.[19]

Definition

[edit]

Generally speaking, self-medication is defined as "the use of drugs to treat self-diagnosed disorders or symptoms, or the intermittent or continued use of a prescribed drug for chronic or recurrent disease or symptoms".[20][21]

Self-medication can be defined as the use of drugs to treat an illness or symptom when the user is not a medically qualified professional. The term is also used to include the use of drugs outside their license or off-label.

Psychology and psychiatry

[edit]

Self-medication hypothesis

[edit]

As different drugs have different effects, they may be used for different reasons. According to the self-medication hypothesis (SMH), the individuals' choice of a particular drug is not accidental or coincidental, but instead, a result of the individuals' psychological condition, as the drug of choice provides relief to the user specific to his or her condition. Specifically, addiction is hypothesized to function as a compensatory means to modulate effects and treat distressful psychological states, whereby individuals choose the drug that will most appropriately manage their specific type of psychiatric distress and help them achieve emotional stability.[22][23]

The self-medication hypothesis (SMH) originated in papers by Edward Khantzian, Mack and Schatzberg,[24] David F. Duncan,[25] and a response to Khantzian by Duncan.[26] The SMH initially focused on heroin use, but a follow-up paper added cocaine.[27] The SMH was later expanded to include alcohol,[28] and finally all drugs of addiction.[22][29][5]

According to Khantzian's view of addiction, drug users compensate for deficient ego function[24] by using a drug as an "ego solvent", which acts on parts of the self that are cut off from consciousness by defense mechanisms.[22] According to Khantzian,[27] drug dependent individuals generally experience more psychiatric distress than non-drug dependent individuals, and the development of drug dependence involves the gradual incorporation of the drug effects and the need to sustain these effects into the defensive structure-building activity of the ego itself. The addict's choice of drug is a result of the interaction between the psychopharmacologic properties of the drug and the affective states from which the addict was seeking relief. The drug's effects substitute for defective or non-existent ego mechanisms of defense. The addict's drug of choice, therefore, is not random.

While Khantzian takes a psychodynamic approach to self-medication, Duncan's model focuses on behavioral factors. Duncan described the nature of positive reinforcement (e.g., the "high feeling", approval from peers), negative reinforcement (e.g. reduction of negative affect) and avoidance of withdrawal symptoms, all of which are seen in those who develop problematic drug use, but are not all found in all recreational drug users.[25] While earlier behavioral formulations of drug dependence using operant conditioning maintained that positive and negative reinforcement were necessary for drug dependence, Duncan maintained that drug dependence was not maintained by positive reinforcement, but rather by negative reinforcement. Duncan applied a public health model to drug dependence, where the agent (the drug of choice) infects the host (the drug user) through a vector (e.g., peers), while the environment supports the disease process, through stressors and lack of support.[25][30]

Khantzian revisited the SMH, suggesting there is more evidence that psychiatric symptoms, rather than personality styles, lie at the heart of drug use disorders.[22] Khantzian specified that the two crucial aspects of the SMH were that (1) drugs of abuse produce a relief from psychological suffering and (2) the individual's preference for a particular drug is based on its psychopharmacological properties.[22] The individual's drug of choice is determined through experimentation, whereby the interaction of the main effects of the drug, the individual's inner psychological turmoil, and underlying personality traits identify the drug that produces the desired effects.[22]

Meanwhile, Duncan's work focuses on the difference between recreational and problematic drug use.[31] Data obtained in the Epidemiologic Catchment Area Study demonstrated that only 20% of drug users ever experience an episode of drug abuse (Anthony & Helzer, 1991), while data obtained from the National Comorbidity Study demonstrated that only 15% of alcohol users and 15% of illicit drug users ever become dependent.[32] A crucial determinant of whether a drug user develops drug abuse is the presence or absence of negative reinforcement, which is experienced by problematic users, but not by recreational users.[33] According to Duncan, drug dependence is an avoidance behavior, where an individual finds a drug that produces a temporary escape from a problem, and taking the drug is reinforced as an operant behavior.[25]

Specific mechanisms

[edit]

Some people who have a mental illness attempt to correct their illnesses by using certain drugs. Depression is often self-medicated by the use of alcohol, tobacco, cannabis, or other mind-altering drugs.[34] While this may provide immediate relief of some symptoms such as anxiety, it may evoke and/or exacerbate some symptoms of several kinds of mental illnesses that are already latently present,[35] and may lead to addiction or physical dependency, among other side effects of long-term use of the drug. This does not differ significantly from the potential effects of drugs provided by physicians, which are equally capable of producing dependency and/or addiction and also have side effects arising from long-term use.

People with post-traumatic stress disorder have been known to self-medicate, as well as many individuals without this diagnosis who have experienced psychological trauma.[36]

Due to the different effects of the different classes of drugs, the SMH postulates that the appeal of a specific class of drugs differs from person to person. In fact, some drugs may be aversive for individuals for whom the effects could worsen affective deficits.[22]

CNS depressants

[edit]

Alcohol and sedative/hypnotic drugs, such as barbiturates and benzodiazepines, are central nervous system (CNS) depressants that lower inhibitions via anxiolysis. Depressants produce feelings of relaxation and sedation, while relieving feelings of depression and anxiety. Though they are generally ineffective antidepressants, as most are short-acting, the rapid onset of alcohol and sedative/hypnotics softens rigid defenses and, in low to moderate doses, provides relief from depressive affect and anxiety.[22][23] As alcohol also lowers inhibitions, alcohol is also hypothesized to be used by those who normally constrain emotions by attenuating intense emotions in high or obliterating doses, which allows them to express feelings of affection, aggression and closeness.[23][29] Most patients that have been hospitalized for substance use or alcohol dependence reported using drugs in response to depressive symptoms. This type of misuse is more likely in men than in women. This makes diagnosing a psychiatric disorder very difficult in substance abusers, because of self medicating.[37]

Alcohol
[edit]
Main article: Alcohol (drug) § Self-medication

People with social anxiety disorder commonly use alcohol to overcome their highly set inhibitions.[38]

Psychostimulants

[edit]

Psychostimulants, such as cocaine, amphetamines, methylphenidate, caffeine, and nicotine, produce improvements in physical and mental functioning, including increased energy and alertness. Stimulants tend to be most widely used by people with attention deficit hyperactivity disorder (ADHD), which can either be diagnosed or undiagnosed. Because a significant portion of people with ADHD have not been diagnosed they are more prone to using stimulants like caffeine, nicotine or pseudoephedrine to mitigate their symptoms. Unawareness concerning the effects of illicit substances such as cocaine, methamphetamine or mephedrone can result in self-medication with these drugs by individuals affected with ADHD symptoms. This self medication can effectively prevent them from getting diagnosed with ADHD and receiving treatment with stimulants like methylphenidate and amphetamines.

Stimulants also can be beneficial for individuals who experience depression, to reduce anhedonia[23] and increase self-esteem,[28] however in some cases depression may occur as a comorbid condition originating from the prolonged presence of negative symptoms of undiagnosed ADHD, which can impair executive functions, resulting in lack of motivation, focus and contentment with one's life, so stimulants may be useful for treating treatment-resistant depression, especially in individuals thought to have ADHD. The SMH also hypothesizes that hyperactive and hypomanic individuals use stimulants to maintain their restlessness and heighten euphoria.[23][27][28] Additionally, stimulants are useful to individuals with social anxiety by helping individuals break through their inhibitions.[23] Some reviews suggest that students use psychostimulants to self medicate for underlying conditions, such as ADHD, depression or anxiety.[5]

Opiates

[edit]

Opiates, such as heroin and morphine, function as an analgesic by binding to opioid receptors in the brain and gastrointestinal tract. This binding reduces the perception of and reaction to pain, while also increasing pain tolerance. Opiates are hypothesized to be used as self-medication for aggression and rage.[27][29] Opiates are effective anxiolytics, mood stabilizers, and anti-depressants, however, people tend to self-medicate anxiety and depression with depressants and stimulants respectively, though this is by no means an absolute analysis.[23][39][40]

Modern research into novel antidepressants targeting opioid receptors suggests that endogenous opioid dysregulation may play a role in medical conditions including anxiety disorders, clinical depression, and borderline personality disorder.[41][42][43] BPD is typically characterized by sensitivity to rejection, isolation, and perceived failure, all of which are forms of psychological pain.[44] As research suggests that psychological pain and physiological pain both share the same underlying mechanism, it is likely that under the self-medication hypothesis some or most recreational opioid users are attempting to alleviate psychological pain with opioids in the same way opioids are used to treat physiological pain.[45][46][47][48]

Cannabis

[edit]
See also: Cannabis use and trauma

Cannabis is paradoxical in that it simultaneously produces stimulating, sedating and mildly psychedelic properties and both anxiolytic or anxiogenic properties, depending on the individual and circumstances of use. Depressant properties are more obvious in occasional users, and stimulating properties are more common in chronic users. Khantzian noted that research had not sufficiently addressed a theoretical mechanism for cannabis, and therefore did not include it in the SMH.[23]

Effectiveness

[edit]

Self-medicating excessively for prolonged periods of time with benzodiazepines or alcohol often makes the symptoms of anxiety or depression worse. This is believed to occur as a result of the changes in brain chemistry from long-term use.[49][50][51][52][53] Of those who seek help from mental health services for conditions including anxiety disorders such as panic disorder or social phobia, approximately half have alcohol or benzodiazepine dependence issues.[54]

Sometimes anxiety precedes alcohol or benzodiazepine dependence but the alcohol or benzodiazepine dependence acts to keep the anxiety disorders going, often progressively making them worse. However, some people addicted to alcohol or benzodiazepines, when it is explained to them that they have a choice between ongoing poor mental health or quitting and recovering from their symptoms, decide on quitting alcohol or benzodiazepines or both. It has been noted that every individual has an individual sensitivity level to alcohol or sedative hypnotic drugs, and what one person can tolerate without ill health, may cause another to experience very ill health, and even moderate drinking can cause rebound anxiety syndrome and sleep disorders. A person experiencing the toxic effects of alcohol will not benefit from other therapies or medications, as these do not address the root cause of the symptoms.[54]

Nicotine addiction seems to worsen mental health problems. Nicotine withdrawal depresses mood, increases anxiety and stress, and disrupts sleep. Although nicotine products temporarily relieve their nicotine withdrawal symptoms, an addiction causes stress and mood to be worse on average, due to mild withdrawal symptoms between hits. Nicotine addicts need the nicotine to temporarily feel normal.[7][55] Nicotine industry marketing has claimed that nicotine is both less harmful and therapeutic for people with mental illness, and is a form of self-medication. This claim has been criticised by independent researchers.[6]

Self medicating is a very common precursor to full addictions and the habitual use of any addictive drug has been demonstrated to greatly increase the risk of addiction to additional substances due to long-term neuronal changes.[citation needed] Addiction to any/every drug of abuse tested so far has been correlated with an enduring reduction in the expression of GLT1 (EAAT2) in the nucleus accumbens and is implicated in the drug-seeking behavior expressed nearly universally across all documented addiction syndromes. This long-term dysregulation of glutamate transmission is associated with an increase in vulnerability to both relapse-events after re-exposure to drug-use triggers as well as an overall increase in the likelihood of developing addiction to other reinforcing drugs. Drugs which help to re-stabilize the glutamate system such as N-acetylcysteine have been proposed for the treatment of addiction to cocaine, nicotine, and alcohol.[56]

Infectious diseases

[edit]

In 89% of countries, antibiotics can be prescribed only by a doctor and supplied only by a pharmacy.[57] Self-medication with antibiotics is defined as "the taking of medicines on one's own initiative or on another person's suggestion, who is not a certified medical professional". It has been identified as one of the primary reasons for the evolution of antimicrobial resistance.[12]

Self-medication with antibiotics is an unsuitable way of using them but a common practice in developing countries.[58] Many people resort to that out of necessity when access to a physician is unavailable because of lockdowns and GP surgery closures, or when the patients have a limited amount of time or money to see a prescribing doctor.[59] While being cited as an important alternative to a formal healthcare system where it may be lacking, self-medication can pose a risk to both the patient and community as a whole. The reasons behind self-medication are unique to each region and can relate to health system, societal, economic, health factors, gender, and age. Risks include allergies, lack of cure, and even death.[60]

Besides developing countries, self-medication with antibiotics is also a problem for higher-income countries. In the European Union the average prevalence was 7% in 2016 with the highest rates in southern countries. There are high rates of self-medication with antibiotics in Russia (83%), Central America (19%) and Latin America (14-26%) too.[61]

Two significant issues with self-medication are the lack of knowledge of the public on, firstly, the dangerous effects of certain antimicrobials (for example, ciprofloxacin, which can cause tendonitis, tendon rupture and aortic dissection)[62][63] and, secondly, broad microbial resistance and when to seek medical care if the infection is not clearing.[64]

Also inappropriate use of over-the-counter ibuprofen or other nonsteroidal anti-inflammatory drugs during winter influenza outbreaks can lead to death, e.g. due to haemorrhagic duodenitis induced by ibuprofen, or the consequences of exceeding the recommended doses of paracetamol by combining doses of the generic product with proprietary flu-remedies and Tylex (paracetamol and codeine).[65]

In a questionnaire designed to evaluate self-medication rates amongst the population of Khartoum, Sudan, 48.1% of respondents reported self-medicating with antibiotics within the past 30 days, whereas 43.4% reported self-medicating with antimalarials, and 17.5% reported self-medicating with both. Overall, the total prevalence of reported self-medication with one or both classes of anti-infective agents within the past month was 73.9%.[21] Furthermore, according to the associated study, data indicated that self-medication "varies significantly with a number of socio-economic characteristics" and the "main reason that was indicated for the self-medication was financial constraints".[21]

Similarly, in a survey of university students in southern China, 47.8% of respondents reported self-medicating with antibiotics.[66]

Other uses

[edit]

One area of DIY medicine is self-administered pharmaceutical drugs that are obtained without a prescription, as in the case of DIY transgender hormone therapy which is common among trans people.[67] Prescription-only lifestyle drugs such as those to treat erectile dysfunction, male pattern baldness, and obesity are often purchased online by people who have no diagnosis or prescription.[68][69] In 2017, the United Kingdom legalized the sale of sildenafil (Viagra) over the counter in part to cut down on the number of men buying it online from unlicensed pharmacies.[70]

Self-managed abortion with medication is safe and effective, but is illegal in some jurisdictions.[71][72] Before the current medication had been developed and in places where abortion is illegal, people may resort to unsafe methods of self-managed abortion.[73][74]

Another area is the creation of medical devices, such as PPE for protection against COVID-19[75] and epinephrine injectors.[76] Some people with insulin-dependent diabetes have created their own automated insulin delivery systems.[77][78] One review found that "the quality of glucose control achieved with DIY AID systems is impressively good".[79] With DIY brain stimulation, individuals with depression create their own devices to access an experimental treatment.[80][81] Other people self-administer fecal transplant as a treatment for various diseases.[82]

Physicians and medical students

[edit]

In a survey of West Bengal, India undergraduate medical school students, 57% reported self-medicating. The type of drugs most frequently used for self-medication were antibiotics (31%), analgesics (23%), antipyretics (18%), antiulcerics (9%), cough suppressants (8%), multivitamins (6%), and anthelmintics (4%).[83]

Another study indicated that 53% of physicians in Karnataka, India reported self-administration of antibiotics.[84]

Children

[edit]

A study of Luo children in western Kenya found that 19% reported engaging in self-treatment with either herbal or pharmaceutical medicine. Proportionally, boys were much more likely to self-medicate using conventional medicine than herbal medicine as compared with girls, a phenomenon which was theorized to be influenced by their relative earning potential.[85]

Regulation

[edit]
Main article: Regulation of therapeutic goods

Self-medication is highly regulated in much of the world and many classes of drugs are available for administration only upon prescription by licensed medical personnel. Safety, social order, commercialization, and religion have historically been among the prevailing factors that lead to such prohibition.

People trying to buy pharmaceutical drugs online without a prescription may be the victim of fraud, phishing, or receive counterfeit medication.[86] Selling prescription drugs to people without a valid prescription is illegal in many jurisdictions and can be considered an example of transnational organized crime.[87] In a 2021 article, Jack E. Fincham argues that unlicensed sales of prescription drugs online are a significant public health threat. It is also possible to obtain controlled substances such as amphetamine, benzodiazepines, and Z-drugs online without a prescription.[88]

See also

[edit]

References

[edit]

Further reading

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Self-medication

View on Grokipedia
from Grokipedia
Self-medication is the selection and use of medicines by individuals to treat self-recognized illnesses or self-diagnosed conditions without the involvement of a healthcare professional. This practice includes pharmaceuticals such as over-the-counter analgesics, leftover prescription antibiotics, and herbal remedies, as well as, in nonhuman animals, the targeted consumption of plants with bioactive compounds exhibiting antiparasitic, antibacterial, or anti-inflammatory properties. Empirical evidence from systematic reviews documents such behaviors in at least 25 primate species across multiple continents, where sick individuals selectively ingest or apply specific plant parts not typically part of their diet, suggesting an adaptive mechanism to counter pathogens or reduce symptoms. In humans, self-medication prevails globally, with meta-analyses of studies from 2000 to 2018 reporting pooled rates ranging from 12.6% to 95.1% across regions, highest in low- and middle-income countries due to limited healthcare access and economic constraints. Among students, a demographic often surveyed for its , rates reach approximately 70%, driven by prior experience, convenience, and perceived minor ailments like headaches or colds. Commonly self-administered agents include nonsteroidal drugs for , antacids for dyspepsia, and antibiotics for presumed infections, though the latter significantly contributes to by enabling incomplete courses, suboptimal dosing, and treatment of viral rather than bacterial etiologies. While self-medication can alleviate trivial symptoms and ease burdens on overburdened systems for accessible remedies, causal risks predominate in empirical data, including adverse reactions, masking of underlying pathologies, pharmacokinetic interactions, and heightened morbidity from incorrect . Surveys among high-prevalence groups, such as medical students in resource-limited settings, reveal over 80% self-use, correlating with regional resistance patterns in pathogens like and . These outcomes underscore self-medication's dual nature: an evolutionarily conserved response yielding short-term relief but, absent oversight, fostering long-term threats like widespread resistance and delayed professional intervention.

Definition and Scope

Core Definition

Self-medication refers to the practice whereby individuals select and administer medicinal products to address self-perceived illnesses or symptoms without consulting or receiving guidance from a healthcare professional. This encompasses over-the-counter (OTC) drugs, herbal remedies, and the reuse of previously prescribed medications for new or recurrent self-diagnosed conditions, often driven by factors such as accessibility, cost, and perceived urgency. The (WHO) defines it as "the selection and use of medicines by individuals to treat self-recognized illnesses or symptoms," emphasizing consumer initiative in both and treatment. Key elements across definitions include self-recognition of health issues, independent choice of therapeutic agents, and self-administration, typically excluding professional oversight to distinguish it from prescribed therapy. A 2022 scoping review of 65 studies identified common components: nonparticipation of health professionals in 62% of definitions, self-diagnosis or self-treatment in 51%, and specification of medication types (e.g., OTC or prescription reuse) in 46%, though heterogeneity persists due to varying inclusions like medicine sharing or nonadherence. Variations may extend to intermittent use of chronic prescriptions for symptom management or even aesthetic purposes, but core consensus centers on layperson-led pharmacotherapy for minor or familiar ailments. Responsible self-medication, as framed by organizations like the WHO and , limits the practice to legally available, registered nonprescription medicines for self-limiting conditions, aiming to promote while mitigating risks such as masking serious . This contrasts with irresponsible forms that involve unverified sources or inappropriate agents, potentially leading to adverse outcomes, though the practice itself remains a widespread component of primary healthcare in resource-constrained settings.

Distinctions from Prescribed Use and Substance Abuse

Self-medication is characterized by the autonomous selection and use of pharmacological agents, including over-the-counter medications, herbal remedies, or non-prescribed substances, to address self-perceived health issues without prior consultation from a qualified healthcare professional. In contrast, prescribed medication use entails a clinician's evaluation, diagnosis, and tailored regimen, incorporating specified dosages, duration, and follow-up to optimize therapeutic outcomes while mitigating risks such as drug interactions or contraindications. This professional oversight in prescribed scenarios reduces the likelihood of errors in self-assessment, which in self-medication can result in suboptimal treatment, masking of underlying pathologies, or exacerbation of conditions due to unmonitored polypharmacy. For instance, a 2023 pharmacoepidemiological analysis identified self-medication as involving unguided application of agents like analgesics or antibiotics, heightening vulnerability to adverse reactions compared to supervised prescriptions. Distinguishing self-medication from substance abuse hinges on intent, pattern, and consequences, though overlaps exist where self-initiated use transitions to pathological dependence. Substance abuse, formally termed substance use disorder in diagnostic frameworks like DSM-5, manifests as a cluster of cognitive, behavioral, and physiological symptoms including compulsive consumption, tolerance development, withdrawal upon cessation, and persistence despite interpersonal, occupational, or health harms, often driven by reinforcement unrelated to symptom alleviation. Self-medication, by definition, pursues targeted relief from discerned symptoms—such as pain, anxiety, or insomnia—without inherent compulsion or disregard for consequences, positioning it as a coping mechanism rather than a primary disorder. Empirical evidence from cohort studies indicates that while self-medication with substances like alcohol or opioids may initially align with self-perceived therapeutic needs, it correlates with elevated risk for escalating to abuse in approximately 20-30% of cases involving untreated mental health comorbidities, per the self-medication hypothesis originally proposed in clinical observations of addictive disorders. Nonetheless, not all self-medication culminates in abuse; episodic, low-dose applications for minor ailments, such as antipyretics for fever, typically lack the diagnostic criteria of dependence seen in abuse trajectories.
AspectSelf-MedicationPrescribed Use
OversightNone; individual initiativeProfessional and monitoringPathological; no therapeutic intent dominates
IntentSymptom self-reliefClinician-directed treatmentCompulsive, often euphoria-seeking or avoidance
Risk ProfileDosage errors, interactions, delayed careMinimized via guidanceTolerance, withdrawal, multisystem harm
Outcome PotentialResolution or progression to misuse with adherenceDependence and impairment
This framework underscores self-medication's intermediary position: a pragmatic response to accessible remedies that diverges from both regulated prescription paradigms and the dysregulated cycles of , yet warrants caution given its documented pathway to the latter in susceptible populations.

Evolutionary and Historical Foundations

Zoopharmacognosy in Animals

encompasses observed behaviors in which wild animals selectively ingest or apply non-nutritional substances, such as or soils, to counteract parasites, infections, or other ailments, as evidenced by field studies correlating usage with states and pharmacological validation of active compounds. In , chimpanzees (Pan troglodytes) in were first documented in 1983 folding and swallowing whole leaves of Aspilia species without mastication, a absent in healthy individuals but prevalent during parasitic infections; these leaves contain thiarubrine A, a with nematocidal and properties that mechanically and chemically expel intestinal worms. Similarly, chimpanzees consume the bitter of when infected with nematodes, as the plant's lactones exhibit effects , with usage rates increasing up to 10-fold in symptomatic animals compared to controls. A 2024 study in Uganda's Budongo identified targeted consumption of boonei dead wood by parasitized chimpanzees, showing strong antibacterial activity against (MIC 32 μg/mL) and , alongside bark and resin, which demonstrated potency (IC50 0.55 μg/mL) and efficacy against . Bonobos (Pan paniscus) exhibit analogous leaf-swallowing of Manniophyton fulvum, correlating with elevated parasite loads and potentially aiding via anti-inflammatory compounds. In birds, self-medication often involves prophylactic nest-lining with aromatic plants to mitigate microbial threats to offspring; European starlings (Sturnus vulgaris) preferentially incorporate (Achillea millefolium) and other volatile-oil-rich herbs, which reduce ectoparasite infestations and bacterial growth in nest material, as demonstrated by controlled experiments showing 30-50% lower pathogen loads in treated nests. Great bustards (Otis tarda) in selectively forage on Sanguisorba minor and Ononis aragonensis during breeding seasons, ingesting higher quantities when parasite burdens rise; these plants contain and active against , nematodes, and fungi , supporting reduced infection rates in consumers. Among insects, monarch butterflies (Danaus plexippus) engage in therapeutic and preventive self-medication by preferentially ovipositing on and consuming milkweed (Asclepias spp.) varieties elevated in cardenolides, toxic cardiac glycosides that infected larvae sequester to combat Ophryocystis elektroscirrha protozoan parasites; parasitized butterflies fed high-cardenolide milkweed exhibit 20-30% longer lifespans and increased flight endurance, while uninfected ones avoid such plants to minimize toxicity costs. Woolly bear caterpillars (Pyrrharctia isabella) ingest alkaloid-rich plants like Epilobium spp. to produce epilactoketal, deterring tachinid fly parasitoids, with field data showing selective consumption only by at-risk individuals. Other examples include baboons (Papio spp.) consuming plant leaves to combat schistosome flatworms and parrots geophagizing clay soils to adsorb dietary toxins and supply minerals during stress, behaviors pharmacologically linked to reduced gastrointestinal distress. These patterns, while suggestive of adaptive self-medication, require distinguishing from incidental , as supported by condition-dependent selectivity and efficacy in over 20 documented across taxa.

Historical Practices in Humans

Prehistoric humans engaged in self-medication through the consumption of natural substances, such as geophagy—ingesting clay or earth—for its potential detoxifying and effects, a practice evidenced in archaeological findings and likely emulated from animal behaviors observed over hundreds of thousands of years. Around 60,000 years ago in , , Neanderthals or early modern humans used plants like yarrow (Achillea millefolium) as an and for treating wounds and infections, and mallow () in infusions for , indicating rudimentary self-treatment via gathered botanicals. Similarly, birch polypore fungus (Piptoporus betulinus) served as a , as found in the remains of the Iceman circa 3300 BCE in the European Alps. This knowledge was transmitted orally, often by women responsible for and administering remedies in small kin groups. In ancient civilizations, humans expanded self-medication by drawing on observations of animal , as documented in classical texts. in the 4th century BCE noted dogs vomiting after eating grass to purge intestinal parasites and bears consuming post-hibernation for nutritional replenishment, insights that informed human herbal uses. in the 1st century CE described deer applying dittany (a wild ) to arrow wounds and elephants using leaves against infections, practices that paralleled folk remedies among and Romans for similar ailments using accessible plants like and derivatives. These accounts reflect trial-and-error experimentation with local , independent of formalized priesthoods or physicians, for conditions like wounds, digestive issues, and poisonings. Medieval European practices continued this tradition through folk and monastic herbalism, where communities relied on self-prepared remedies due to scarce medical access. from the , such as the , recorded bears treating sores with mullein, influencing laypeople to use similar plants for skin conditions and inflammations. In the 14th century, Arabic scholar Ibn al-Durayhim detailed wild goats applying moss to wounds, a technique adopted in European folk medicine for its properties. and self-treatment predominated, involving decoctions from gardens and wilds for common ailments like fevers and pains, as care was often unavailable or distrusted amid prevailing superstitions. By the (17th century), self-medication shifted toward systematic household production in , exemplified by English gentlewoman Elizabeth Freke's collection of approximately 9,000 recipes for cure-alls and targeted remedies against weaknesses, pains, and digestive disorders. Families procured ingredients like herbs, minerals, and animal products, employing basic and compounding methods without apothecary oversight, blending commercial purchases with domestic preparation for "just-in-case" storage. Women frequently led these efforts, treating kin via empirically derived formulas passed through manuscripts, underscoring amid emerging but uneven medical .

Prevalence and Patterns

Global and Regional Statistics

A and of 69 studies involving 41,620 individuals, covering data from 2000 to 2018, estimated the global prevalence of self-medication at 67% (95% CI: 62–73%). This figure reflects practices including use, leftover prescription reuse, and herbal remedies without professional oversight, with higher rates observed in regions of greater accessibility and lower healthcare access. Prevalence exhibits substantial continental variation, as summarized below based on the same :
ContinentPrevalence (95% CI)Number of Studies
71% (63–78%)42
74% (56–86%)7
55.9% (42.4–68.5%)16
60% (40.2–77%)4
's elevated rate correlates with widespread availability of non-prescription pharmaceuticals and cultural norms favoring self-treatment. 's figure is driven primarily by Eastern European studies, where economic factors and pharmacy dispensing practices contribute. African rates show heterogeneity linked to informal markets and limited formal healthcare, with sub-regional medians around 55.7%. In , self-medication appears lower; in the United States, roughly 40% of the general population reports using medications without professional consultation, influenced by regulatory controls on prescription drugs and robust over-the-counter options. WHO regional data from the meta-analysis indicate rates of 74% in , 74% in (predominantly Eastern), and 72% (95% CI: 63–80%) in the . These disparities underscore the role of socioeconomic, regulatory, and infrastructural factors in self-medication patterns.

Demographic and Influencing Factors

Self-medication prevalence exhibits notable variations across demographic groups. Studies consistently report higher rates among s compared to males; for instance, among university students, female prevalence reached 76.6% (95% CI: 65.0–85.2%), exceeding the 66.9% (95% CI: 56.4–75.9%) observed in males, potentially attributable to greater health-seeking behaviors or familiarity with medications from prior use. Age also influences patterns, with elevated rates often seen in younger adults aged 20–40 years, such as 82% in the 21–40 age group in one analysis of utilization, contrasting with lower engagement among those over 60, where reduced or caution may play roles. Educational attainment correlates positively with self-medication frequency, as individuals with higher education levels demonstrate greater awareness of drug indications, leading to rates as high as 89% among those with academic backgrounds; this association stems from enhanced pharmacological knowledge rather than mere . Socioeconomic factors, including , further modulate practices, with higher family linked to increased self-medication through improved access to over-the-counter options and reduced perceived barriers to medications independently. Lower-income groups, conversely, may self-medicate more out of necessity due to healthcare inaccessibility, though data indicate mixed effects depending on regional contexts. Influencing factors extend beyond demographics to include healthcare access, prior illness experience, and cultural norms. Limited availability of professional medical services drives self-medication in resource-constrained settings, where individuals rely on readily available pharmaceuticals to address acute symptoms like or infections. derived from previous prescriptions or informal sources empowers users but can foster overconfidence, particularly among health professionals or students, who report rates exceeding 55% influenced by perceived expertise. Economic pressures, such as medication costs and consultation fees, alongside time constraints, amplify this behavior globally, with systematic reviews identifying these as primary drivers in both developed and developing regions. Cultural attitudes toward in , especially in urban or medically literate populations, further perpetuate the practice without necessarily correlating with adverse outcomes when based on accurate .

Underlying Mechanisms and Rationales

Self-Medication Hypothesis in

The self-medication hypothesis posits that individuals with underlying psychiatric vulnerabilities selectively use specific substances to alleviate or with distressing symptoms, rather than substance use being primarily driven by hedonistic or social reinforcement motives. Originally formulated by Edward Khantzian in 1985, the theory emerged from clinical observations of patients with addictive disorders, suggesting that drug preferences are not random but matched to self-perceived emotional or psychological deficits—such as opioids for overwhelming agitation or , with individuals suffering from untreated depression, anxiety, PTSD, or chronic emotional pain often turning to opioids to numb emotional distress, reduce anxiety, or obtain short-term euphoria, potentially leading to repeated use and addiction; stimulants for or , and sedatives for anxiety or . This framework emphasizes an adaptive, albeit maladaptive, intent behind initial use, where substances serve as pharmacological self-regulation tools in the absence of effective alternative mechanisms or professional treatment. Empirical support for the hypothesis draws from longitudinal and epidemiological data indicating that certain mental disorders often precede the onset of substance use disorders, consistent with self-medication patterns. For instance, prospective studies have shown temporal precedence of anxiety disorders over , with individuals reporting purposeful use of alcohol to reduce tension or panic symptoms. Alcohol is commonly employed as a maladaptive coping strategy, termed "drinking to cope," particularly for chronic stress, offering short-term relief from anxiety, negative emotions, or tension; however, it frequently results in escalated consumption, alcohol dependence, deteriorated mental health, and elevated risk of alcohol use disorders. Similarly, in populations with (PTSD) or depression, self-reported motivations for or use frequently align with symptom relief, such as numbing intrusive thoughts or boosting mood, corroborated by higher rates where psychiatric symptoms predict subsequent substance initiation. Clinical evidence from treatment settings further bolsters this, with patients exhibiting improved functioning when psychiatric symptoms are addressed alongside addiction, implying that self-medication targets genuine underlying distress rather than vice versa. Health authorities recommend healthier coping methods, such as exercise, therapy, social support, or mindfulness, over alcohol use. However, the hypothesis faces significant criticisms for relying heavily on retrospective self-reports and clinical anecdotes, which may introduce or post-hoc rationalization, rather than rigorous causal evidence from controlled trials. Some research challenges the specificity of drug-symptom matching, finding that substance use can exacerbate or even precipitate issues, as seen in studies where alcohol consumption worsens depressive symptoms over time or where stimulants induce anxiety in vulnerable individuals. Critics also note a lack of robust prospective disproving alternative explanations, such as genetic vulnerabilities or bidirectional , and argue that the model risks minimizing personal agency by framing as a symptom-driven response rather than a choice influenced by broader factors like or environmental cues. In specific contexts like and use, genetic and neurobiological evidence suggests smoking may reflect inherent traits rather than deliberate self-medication for cognitive deficits. Despite these limitations, the hypothesis remains influential in integrated treatment approaches, advocating for interventions that prioritize psychiatric stabilization to reduce reliance on self-medication.

Physiological and Behavioral Drivers for Physical Conditions

Self-medication for physical conditions is primarily driven by physiological imperatives arising from acute symptoms that disrupt and induce discomfort, prompting individuals to seek rapid symptom alleviation. , mediated by nociceptors and inflammatory cytokines, signals tissue damage or , activating neural circuits in the brain's reward and aversion systems that motivate analgesic procurement to restore functional equilibrium. Similarly, fever, an adaptive elevation in core body temperature orchestrated by hypothalamic reset via pyrogens like interleukin-1, enhances immune function against but generates , , and fatigue through prostaglandin-mediated effects, compelling the use of antipyretics such as acetaminophen to mitigate these burdens despite potential trade-offs in pathogen clearance. Gastrointestinal distress, including and from enteric s, further exemplifies how visceral afferent signals drive emetic or antidiarrheal self-administration to avert and nutrient loss. Behavioral drivers reinforce these physiological cues through learned associations and pragmatic decision-making, where individuals appraise symptoms as mild and self-limiting based on prior exposures, favoring over-the-counter remedies for immediacy. Empirical surveys indicate that familiarity with symptoms and medications, often from recurrent minor ailments like colds or headaches, accounts for up to 40-60% of self-medication instances, as people replicate successful past outcomes without professional consultation. Urgency for relief, coupled with barriers like healthcare access delays or costs, prompts autonomous action; for instance, in resource-limited settings, 50-80% of acute respiratory or febrile episodes lead to self-treatment with analgesics or antimicrobials due to perceived low severity and high availability. Habitual patterns emerge from cultural norms and family influences, where parental modeling transmits behaviors, amplifying reliance on non-prescribed interventions for common conditions like or infections over formal care. These drivers interact causally: physiological distress lowers the threshold for , while repeated self-medication entrenches habits via , as symptom resolution reinforces the strategy. Studies in diverse populations, including health professionals, reveal that professional knowledge paradoxically heightens self-medication rates for physical symptoms by enhancing perceived competence in dosing familiar drugs like for fever or ibuprofen for . However, this assumes accurate , which falters when symptoms mask underlying pathologies, underscoring the tension between adaptive relief-seeking and risks of masking serious disease progression.

Common Applications

Treatment of Infectious Diseases

Self-medication for infectious diseases commonly targets symptoms of bacterial, viral, and parasitic infections, with representing the most frequently used agents despite many infections being viral and thus unresponsive to them. Global pooled prevalence of self-medication stands at 43.0% among adults, driven by perceived urgency and prior experience rather than confirmed . infections, including , , and , prompt self-medication in over 50% of cases, often with broad-spectrum antibiotics like amoxicillin (used in 61.1% of instances) or cotrimoxazole. In low- and middle-income countries, self-medication extends to antimalarials for suspected infections, with practices rooted in endemicity and limited healthcare access; prevalence reaches up to 67% in rural settings like . Common agents include artemisinin-based combinations or older drugs like , sourced from pharmacies or leftovers, bypassing diagnostic confirmation via rapid tests. Gastrointestinal infections, such as , also drive use in 90.6% of self-treated cases in some populations, exacerbating selective pressure on gut flora. Household surveys indicate that 60% of families in certain communities self-medicate children under five for acute respiratory infections using over-the-counter syrups, , or decongestants alongside antibiotics, prioritizing symptom relief over etiology. This pattern persists across demographics, with urban adults in regions like and the reporting self-medication rates exceeding 38.8% for agents overall. Sources of drugs include pharmacies without prescriptions (most common), shared family stocks, or informal markets, reflecting barriers like cost and consultation delays.

Management of Pain and Common Symptoms

Self-medication for pain commonly involves over-the-counter (OTC) analgesics such as (acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, which individuals use to alleviate headaches, musculoskeletal , and dental discomfort without professional consultation. In surveys of adults experiencing , approximately 55% report relying on OTC medications as their primary treatment, often citing rapid accessibility and familiarity with dosing from prior use. For conditions, self-medication rates can reach higher levels, with studies indicating that up to 44.8% of respondents initiate use before seeking medical advice, particularly for mild to moderate symptoms. This practice is driven by the perception of low risk for short-term use, though evidence from patient surveys highlights variable adherence to recommended dosages. Common symptoms prompting self-medication include colds, coughs, fever, and gastrointestinal issues, where individuals frequently select symptomatic remedies like decongestants, cough suppressants, antipyretics, or antacids. Headaches and respiratory symptoms such as those associated with the are among the most cited triggers, with rates of self-medication exceeding 75% for headaches and 52% for cold-related complaints in populations. In broader adult cohorts, up to 93% of individuals prefer OTC products for minor ailments before consulting healthcare providers, favoring multi-symptom formulations for convenience. For instance, remains the most utilized agent for fever and mild pain in these contexts, with usage patterns reflecting based on symptom duration and severity. These applications often extend to combined therapies, such as topical analgesics for localized or supplements alongside pharmaceuticals for symptom relief, though empirical data underscore a predominance of pharmaceutical OTC choices due to perceived . Patterns vary by demographics, with younger adults more likely to self-medicate for acute symptoms like sore throats or using readily available products from pharmacies or retail outlets. Overall, such practices account for a significant portion of minor ailment management, supported by regulatory availability of low-risk OTC options designed for self-use.

Use in Mental Health Contexts

Self-medication in involves individuals using alcohol, illicit drugs, or over-the-counter substances without professional guidance to alleviate symptoms of psychiatric conditions such as anxiety, depression, or severe mental illnesses. This practice aligns with the self-medication , which posits that substance use often stems from attempts to self-treat underlying emotional distress, as observed in clinical populations with comorbid substance use and psychiatric disorders. Empirical studies indicate that up to 29.9% of individuals reporting symptoms in the past year engage in such behaviors, particularly with alcohol, marijuana, or other drugs perceived to provide symptomatic relief. Alcohol is among the most commonly employed agents for self-medicating anxiety and mood disturbances, with surveys showing that approximately 14.9% of those with anxiety disorders report using it for this purpose. is frequently selected for depression or stress reduction, driven by its perceived effects, while sedatives and opioids may be sought for acute or linked to psychiatric states. In populations with severe mental illnesses, such as , self-administration of alcohol or stimulants occurs to counteract negative symptoms like or social withdrawal. Longitudinal data reveal that self-medication with alcohol among those with baseline anxiety disorders precedes the onset of alcohol use disorder in 12.6% of cases, underscoring a pattern of initial symptom-targeted use. Prevalence varies by demographic and disorder type; for instance, individuals with mood disorders show elevated rates of drug self-medication motivated by relief from depressive episodes, as evidenced in hospitalized cohorts where specific drug effects were matched to symptom profiles. Among medical professionals, including psychiatrists, self-medication for mild to moderate depression reaches 42.5%, often involving psychotropic drugs obtained informally. These applications reflect a behavioral response to unmet treatment needs or barriers to formal care, though from national surveys links such practices to heightened perceptions of treatable issues prompting substance experimentation.

Empirical Benefits

Accessibility and Cost Savings

Self-medication enhances treatment accessibility by enabling immediate intervention for minor conditions without requiring healthcare provider consultations, particularly in underserved regions. In developing countries, where healthcare is often limited, self-medication ranges from 12.7% to 95%, driven by factors such as geographic barriers and overburdened medical services, allowing individuals to obtain over-the-counter (OTC) remedies directly from pharmacies or vendors. This approach circumvents delays associated with appointment scheduling or travel to facilities, fostering self-reliance in managing commonplace symptoms like or infections. Economically, self-medication generates verifiable cost reductions for both patients and healthcare s. Patients engaging in typically save approximately USD 174 annually on physician visits and USD 160 on medications by treating self-limitations independently. In the United States, non-prescription medications deliver USD 102 billion in annual value to the healthcare , including avoidance of USD 5.2 billion in doctor visits for conditions amenable to self-treatment. At the systemic level, broader adoption amplifies savings. In , reclassifying 5% of prescription drugs to OTC status could yield EUR 16 billion in yearly savings across 25 member states, primarily through reduced outpatient care and public fund expenditures, with country-specific examples including EUR 3.65 billion in and EUR 2.48 billion in . In the , OTC medicines avert £6.4 billion annually in costs by eliminating prescriptions and appointments for self-treatable ailments, while also preventing 164 million missed workdays through quicker recovery. These figures underscore self-medication's role in optimizing , though benefits hinge on responsible use of established OTC products.

Promotion of Individual Autonomy and Self-Care

Self-medication enables individuals to address minor, self-limiting conditions such as allergies, , or gastrointestinal issues without requiring professional consultation, thereby exercising direct control over their decisions and fostering a sense of personal agency. This practice aligns with principles of , where patients assume responsibility for initial treatment using over-the-counter (OTC) medicines, potentially enhancing and decision-making skills when supported by adequate education. For instance, in contexts with high access to information, responsible self-medication reduces dependency on physicians for routine ailments, as evidenced by estimates that up to 40% of visits in the pertain to conditions amenable to self-management. Empirical observations from among university students indicate that self-medication cultivates a of personal responsibility for , with participants describing it as "a matter of personal responsibility" to understand their bodies and make informed choices about medications. This is particularly pronounced in managing time-sensitive or private concerns, such as menstrual issues or minor infections, where individuals prioritize amid barriers like academic pressures or wait times. Pharmacists play a supportive role by providing and evidence-based guidance on OTC options, which further empowers patients to monitor symptoms autonomously while recognizing limits that necessitate referral. Such interactions promote sustainable behaviors, including non-pharmacological strategies like hydration or lifestyle adjustments, contributing to overall maintenance without overburdening healthcare systems. Broader evidence underscores that expanding self-medication opportunities, such as reclassifying suitable prescription drugs to OTC status, correlates with improved patient empowerment and reduced third-party payer costs, as individuals gain in treating familiar conditions independently. In developed settings with robust regulatory oversight and public , this approach has demonstrated value in preventing unnecessary consultations—for example, avoiding millions of annual visits in the United States and for self-treatable issues like or seasonal allergies—while encouraging proactive health behaviors. However, these benefits hinge on individual and access to , highlighting the need for targeted interventions to mitigate risks in less-informed populations.

Risks and Criticisms

Individual Health Hazards

Reliable health sources emphasize taking medications only as prescribed by a doctor or qualified professional, avoiding self-medication due to risks including allergic reactions, intoxication, antibiotic resistance, disease aggravation, and potential death. Essential practices include checking expiration dates, following dosage instructions, storing medications properly, and consulting professionals for guidance. Inappropriate self-medication frequently results in adverse drug reactions (ADRs), with systematic reviews reporting misuse of over-the-counter (OTC) and prescription medications leading to complications such as allergies, intoxications, and dependencies. For instance, during the , self-medication was associated with ADRs in 4.7% to 36% of cases, often due to unmonitored use of antimicrobials or analgesics for undifferentiated symptoms. Elderly individuals face heightened vulnerability, as self-medication contributes to events like from NSAIDs or hepatic injury from overuse, with reviews documenting these as prevalent outcomes in populations over 60. Drug interactions represent another critical hazard, particularly when self-medicators combine OTC drugs with undisclosed prescription therapies or substances like alcohol. Potential interactions occurred in 6.89% of self-medication cases in one study, rising to 13.64% among those with , amplifying risks of such as serotonergic syndromes or cholinergic crises. Case reports highlight severe outcomes, including organ failure from unanticipated synergies, underscoring how lack of pharmacological knowledge leads to unpredictable physiological cascades. Self-medication with psychiatric drugs such as selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines is particularly dangerous, potentially causing serious side effects or life-threatening issues like serotonin syndrome from excessive serotonergic activity with SSRIs, or dependence, overdose, and respiratory depression with benzodiazepines; these require professional diagnosis and supervision to mitigate risks. Incorrect and dosing further endanger individuals by delaying of serious conditions or causing treatment failure. Self-medication often masks symptoms of underlying diseases, such as infections progressing to due to inadequate , with antimicrobial self-use linked to lack of cure in 11.8% of documented instances and rare but fatal complications in others. Specific risks associated with self-medication using antibiotics like Amoxicillin or Cefalexin include ineffectiveness when the drug does not match the infection type, fostering the development of antibiotic-resistant bacteria, allergic reactions that may escalate to anaphylactic shock, side effects such as diarrhea or potential liver and kidney damage, and delaying professional treatment, which can exacerbate the underlying condition. Similarly, self-treatment of severe joint pain with OTC NSAIDs risks gastrointestinal issues such as bleeding or ulcers, contraindications with other conditions, and delays in professional diagnosis requiring blood tests (e.g., for C-reactive protein or rheumatoid factor) to identify underlying etiologies like inflammatory arthritis, necessitating tailored prescription treatments. Overdosing risks escalate with habitual reliance on leftover prescriptions, contributing to accidental toxicities; for example, excessive intake has been tied to in self-medicators treating persistent pain without dose monitoring. Among adolescents and young adults, self-medication prevalence exceeds 50% in some cohorts, correlating with higher incidences of dependency and resistance development at the individual level, where repeated ineffective courses prolong illness and necessitate escalated interventions. Health professionals, despite greater knowledge, exhibit similar patterns, with studies showing 60-70% engaging in self-medication and facing comparable ADR risks due to overconfidence in . Overall, these hazards stem from causal disconnects between symptom perception and , compounded by incomplete adherence to evidence-based dosing, resulting in net harm rather than benefit for many practitioners.

Broader Public Health Implications

Self-medication, particularly with antibiotics, drives the global (AMR) crisis through mechanisms such as incomplete treatment courses, incorrect dosing, and unnecessary use, which selectively pressure bacterial populations to evolve resistance. identifies misuse and overuse of antimicrobials, including self-medication, as primary causes, accelerating the loss of efficacy in treatments for common infections. In surveys of health science students, over 80% reported self-medicating with antibiotics, often broad-spectrum agents, despite awareness of resistance risks, highlighting behavioral patterns that amplify adaptation. These practices yield severe population-level outcomes, including elevated morbidity and mortality; AMR directly accounted for 1.27 million deaths in 2019 and contributed to nearly 5 million more, undermining interventions like and . Resistant infections spread more readily in communities where self-medication evades diagnostic oversight, complicating outbreak containment and fostering transmission of pathogens like multidrug-resistant or . In low- and middle-income countries, where self-medication prevalence exceeds 50% in many populations, this dynamic exacerbates health disparities and strains limited systems. Economically, AMR fueled by such behaviors imposes burdens estimated at US$1 trillion in additional healthcare expenditures by 2050, alongside annual GDP losses of US$1–3.4 trillion by 2030, diverting resources from preventive measures. Self-medication also distorts data by reducing reported cases, hindering epidemiological tracking and policy responses to resistance trends. While access barriers in under-resourced settings motivate these practices, the resultant resistance cycle perpetuates higher treatment costs and reduced productivity across societies.

Regulatory Frameworks

Evolution of Regulations

Prior to the early , self-medication with pharmaceuticals in the United States and many other nations operated with minimal oversight, relying on voluntary standards established by bodies like the U.S. Pharmacopeia in 1820, which compiled drug standards but lacked enforcement mechanisms. Patent medicines, often containing alcohol, , or unproven compounds, were freely marketed directly to consumers for self-treatment of ailments ranging from to infections, leading to widespread misuse and without requirements for safety data or accurate labeling. This era's lax approach stemmed from a market-driven system where efficacy claims were unregulated, fostering an environment of empirical trial-and-error by users but also significant harm from adulterated products. The of 1906 marked the first federal intervention in the U.S., prohibiting the interstate shipment of misbranded or adulterated drugs and mandating ingredient disclosure on labels, in response to exposés like Upton Sinclair's and campaigns against fraudulent remedies. While it curbed overt deception in self-medication products, the Act did not mandate pre-market safety testing or efficacy proof, allowing continued direct consumer access to many substances with only post-market enforcement against violations. Enforcement by the Bureau of Chemistry, precursor to the FDA, focused on labeling compliance rather than restricting self-use, preserving broad availability for over-the-counter (OTC) remedies. The Federal Food, Drug, and Cosmetic Act of 1938 represented a pivotal shift toward safety-focused regulation, requiring manufacturers to prove drugs were safe for intended use before marketing, prompted by the disaster that killed 107 people due to a toxic solvent in an untested liquid form of the . This legislation expanded FDA authority to include cosmetics and devices while implicitly limiting self-medication by enabling the agency to deem certain drugs unsafe without professional oversight, though formal prescription requirements were not yet codified. It introduced factory inspections and penalties for unsafe products, reducing risks in OTC self-medication but increasing barriers for new entrants, as evidenced by the withdrawal of hazardous remedies previously self-administered. The Durham-Humphrey Amendment of 1951 formalized the prescription-OTC dichotomy under the 1938 Act, classifying drugs as prescription-only if unsafe for self-medication without medical supervision, based on criteria like narrow therapeutic indices or potential for . This enabled pharmacists and physicians to recommend OTC options for minor conditions while restricting others, aiming to balance access with harm prevention; by 1951, it influenced the categorization of antibiotics and analgesics, curbing unsupervised use of higher-risk agents. The Kefauver-Harris Amendments of 1962 further tightened controls by mandating proof of both safety and efficacy through adequate clinical trials before approval, following the tragedy that caused thousands of birth defects abroad (averted in the U.S. by FDA delays). These changes applied to both prescription and OTC drugs, leading to the delisting of ineffective self-medication products and stricter advertising rules, with pre-1962 OTC remedies scrutinized for evidence, resulting in some reclassifications or market removals. The amendments shifted regulatory emphasis from reactive enforcement to proactive evidence requirements, diminishing unchecked self-medication with unproven therapies but preserving OTC pathways for substantiated low-risk options. Internationally, regulatory evolution mirrored U.S. developments, with many countries adopting safety and efficacy standards post-World War II; for instance, the European Union's precursor directives in the 1960s-1970s harmonized drug approvals, influencing OTC classifications to permit self-medication for common ailments under guidance. The , through guidelines emerging in the late , endorsed responsible self-medication with OTCs as a means to alleviate healthcare burdens, particularly in resource-limited settings, while cautioning against misuse; by 2022, WHO formalized self-care interventions including OTC access as integral to universal health coverage, building on earlier rational drug use frameworks from the 1980s. Global harmonization efforts via the International Council for Harmonisation since 1990 have standardized testing for OTC switches, facilitating cross-border self-medication while addressing resistance risks from overuse.

Current Global Approaches and Debates

Regulatory frameworks for self-medication vary widely across regions, with developed nations emphasizing prescription requirements for high-risk drugs like antibiotics to mitigate , while many developing countries permit over-the-counter (OTC) sales of such medications due to limited healthcare access. In the United States and , antibiotics are strictly prescription-only, and OTC drugs undergo rigorous and assessments by bodies like the (FDA) and (EMA), restricting self-medication to minor ailments with low-risk products. The (WHO) advocates for responsible self-medication through guidelines that classify suitable products for OTC use based on profiles, data, and low abuse potential, as outlined in its 2000 framework for regulatory assessment, which remains influential despite calls for updates amid rising resistance concerns. In contrast, self-medication practices in low- and middle-income countries often involve unregulated access to s and other pharmaceuticals, exacerbating global ; for instance, in parts of and , up to 70% of use stems from self-medication due to pharmacy dispensing without prescriptions. The WHO's May 2025 guideline on balanced national controlled medicines policies seeks to harmonize access and safety, urging countries to implement for OTC products while promoting education to reduce inappropriate self-use. European data from 2024 indicate a self-medication of 34.3% among the general , correlating with increased adverse reactions (ADRs), prompting debates on tightening OTC switches for certain analgesics and antihistamines. Ongoing debates center on balancing individual and cost savings against risks, particularly antibiotic stewardship; proponents of expanded OTC access argue it alleviates overburdened healthcare systems for self-limiting conditions, as supported by WHO's endorsement of for minor symptoms, while critics highlight causal links to resistance, with self-medication implicated in 20-50% of global . In developing regions, discussions focus on enforcement challenges, with calls for pharmacist-led interventions and digital tracking to curb OTC sales without curbing essential access. Recent analyses (2023-2025) underscore the need for coordinated regulatory actions, including public awareness campaigns and stricter vendor licensing, to address self-medication's role in ADRs and resistance without overly restricting legitimate use.

Special Populations

Children and Adolescents

Self-medication among children is largely initiated by parents or guardians, who frequently administer over-the-counter remedies or leftover prescriptions for acute symptoms such as fever, , and , bypassing professional consultation. In a national survey of 4,608 parents in , 24.21% reported self-medicating their children under age 12 within the past year, with cold and medicines used in 75.45% of cases, followed by respiratory drugs (54.21%) and antibiotics (29.57%). Another study reported a higher of 56.6% among children and adolescents, where mothers handled 51% of administrations and drugstore staff advised 20.1%, primarily for respiratory diseases (17.2%), fever (15%), and (14%). Analgesics and antipyretics accounted for 52.9% of drugs used, alongside medications (15.4%) and antibiotics (8.6%). Adolescents more often self-medicate independently, with prevalence varying substantially from 2% to 92% across international studies, influenced by regional access to medications and cultural norms. Systematic reviews identify , allergies, and fever as the leading complaints prompting use of over-the-counter analgesics, though prescription-only drugs are also misused. In one global analysis, 79.2% of engaged in self-medication, predominantly for similar symptoms. Factors associated with higher rates include lower parental education, urban residence in some contexts, and prior exposure to medications, while graduate-level educated parents show reduced likelihood (adjusted 0.436). These practices carry elevated risks for youth due to immature , higher susceptibility to dosing errors, and potential to obscure serious pathologies. Adverse outcomes include drug interactions, allergic reactions, intoxications, and dependency risks, with self-administration exacerbating and pediatric misuse rates reaching 42.88% for such agents. Inappropriate self-medication correlates with deficient and concurrent substance use, amplifying hazards like overdoses or delayed diagnoses. Children aged 7–18 face over twice the odds of self-medication compared to younger groups ( 2.81), underscoring vulnerabilities in this transitional phase. Empirical data reveal limited benefits, as unsupervised use often yields suboptimal symptom resolution without addressing root causes, contrasting with supervised care that mitigates errors.

Healthcare Professionals

Healthcare professionals, including physicians and nurses, frequently engage in self-medication despite their specialized knowledge of associated risks, with a 2025 in reporting a of 59.4% among 438 surveyed workers, rising to 81.3% for physicians. This practice is driven by factors such as perceived mildness of symptoms (67.3%), easy access to medications (41.2%), and prior successful experiences (40.8%), though knowledge of proper dosing correlates positively while risk awareness acts as a deterrent. Common agents include analgesics (80.8%) and anti-inflammatories (70.8%), with 8.1% reporting adverse effects, highlighting empirical vulnerabilities even among informed users. Ethical guidelines from major medical bodies strongly discourage self-treatment by physicians to preserve clinical objectivity and mitigate risks like diagnostic errors or substance misuse. The American Medical Association's Code of Medical Ethics states that physicians generally should not treat themselves or members, except in rare emergencies or minor issues, due to impaired judgment from personal involvement. Similarly, the advises against routine self-medication, emphasizing that patients—including professionals—should consult independent providers to avoid compromising care quality. Legal restrictions in most U.S. states prohibit self-prescribing controlled substances, while self-prescribing non-controlled substances such as antidepressants is legal in most states (though ethically discouraged) but prohibited in some states like Tennessee except in emergencies, with varying rules underscoring regulatory efforts to curb potential abuse pathways observed in high-prevalence specialties like . Regarding patient self-medication, professionals view it as hazardous, citing causal risks such as masking underlying conditions, adverse drug interactions, incorrect dosing, and contributions to , which empirical data links to delayed diagnoses and worsened outcomes. A majority (54.6%) of surveyed Spanish health professionals prefer formal consultations over self-treatment for patients, attributing poor adherence or undisclosed use to strained doctor-patient dynamics and incomplete histories. Recommendations include routine on disclosing self-medication history, especially with concurrent prescriptions, to enable informed adjustments and prevent complications. In resource-strained contexts, professionals advocate targeted interventions like prioritizing access to over-the-counter guidance while reinforcing first-line consultation for non-trivial symptoms, informed by studies showing self-medication's in minor ailments versus its amplification of burdens when unchecked. Overall, while acknowledging self-medication's occasional utility for self-aware providers in isolated cases, prevailing professional consensus prioritizes supervised care to align with evidence-based risk mitigation.

Populations in Resource-Limited Settings

In resource-limited settings, such as low- and middle-income countries (LMICs), self-medication is driven primarily by barriers to formal healthcare access, including inadequate , high consultation costs, geographic remoteness, and limited of trained providers. These factors compel individuals to seek immediate relief through self-obtained medications, often as a pragmatic response to acute symptoms rather than professional . Systematic reviews indicate that socioeconomic constraints exacerbate this practice, with lower-income populations relying on it due to financial inability to afford prescribed treatments or transport to facilities. rates vary but are notably high; for instance, among rural farmers in disadvantaged areas, self-medication reaches 67%, frequently involving over-the-counter purchases without oversight. Common self-medication involves analgesics for (up to 66.7% of cases) and antibiotics (around 32.5%), sourced from private pharmacies, leftover household supplies, or informal vendors, bypassing prescription requirements. In LMICs, antibiotics are particularly misused for self-treatment of presumed infections like respiratory or urinary symptoms, with incomplete dosing regimens common due to cost-saving measures or symptom resolution before full courses. This pattern persists despite regulatory efforts, as enforcement is weak and economic pressures prioritize affordability over adherence to guidelines. Studies in regions like and highlight urban-rural disparities, with urban dwellers sometimes accessing more drugs via unregulated markets. The practice accelerates (AMR), a critical threat in these settings, where self-medication contributes to pathogen selection pressure through inappropriate use and subtherapeutic exposures. In developing countries, this has led to elevated resistance rates in community-acquired infections, complicating treatment and increasing mortality from otherwise manageable conditions; for example, incomplete courses foster bacterial mutations and survival. Empirical data from LMICs show self-medication as a key driver of AMR alongside poor and drugs, with global estimates linking it to prolonged illness and higher healthcare burdens when resistance necessitates advanced interventions unavailable locally. While it may provide short-term access in underserved areas, the causal link to resistance underscores long-term harms outweighing immediate conveniences.

Recent Developments and Future Directions

Impact of Pandemics like

The , beginning in early 2020, significantly elevated self-medication rates globally due to lockdowns, overwhelmed healthcare systems, and restricted access to professional care, prompting individuals to self-treat symptoms or prophylactically without medical consultation. Studies reported prevalence rates ranging from 44.78% in general populations to over 60% among healthcare workers in regions like , where rates rose from 36.2% pre-pandemic to 60.4% during the crisis. Common practices involved over-the-counter analgesics, antibiotics, vitamins, and unproven -specific remedies, driven by fear of infection and amplified via and early anecdotal reports. Self-medication with repurposed drugs like and surged despite limited evidence of efficacy, leading to documented adverse outcomes including cardiac arrhythmias from hydroxychloroquine toxicity and neurological effects from overdoses, particularly when veterinary formulations were misused. Large-scale randomized trials, such as those published in 2021, confirmed these agents did not reduce mortality or hospitalization rates, while self-initiated use correlated with higher rates of emergency visits and contributed to polypharmacy-induced multiorgan failure in severe cases. self-medication, often for viral symptoms, exacerbated concerns, with surveys indicating widespread prophylactic use unrelated to bacterial co-infections. Public health modeling suggested self-medication may have amplified transmission by masking early symptoms and delaying diagnosis, with one analysis estimating higher spreading rates among self-medicating adults aged 15-64 at onset. In resource-limited settings, while self-medication filled access gaps, it often bypassed evidence-based interventions like , perpetuating cycles of misuse; peer-reviewed syntheses emphasized the need for targeted education to mitigate such risks in future outbreaks.

Emerging Research and Policy Shifts

Recent studies have quantified the global scale of self-medication, with a 2025 meta-analysis of 98 studies across 45 countries estimating a pooled of 43.0% among adults, varying from 10.5% in high-income regions to over 60% in low- and middle-income countries where over-the-counter access persists despite regulations. This practice correlates with through incomplete courses and use for non-bacterial conditions, as demonstrated in 2024 surveys from and Georgia showing 30-40% of respondents self-medicating antibiotics for viral symptoms like colds, often sourced from leftovers or informal vendors. Emerging longitudinal data post-COVID-19 indicate no significant decline in these patterns, with self-medication rates for respiratory issues holding at 45-60% in urban-rural comparisons from and , driven by cost barriers and familiarity rather than alone. Research among specific demographics highlights modifiable determinants, such as a study of university students identifying age (21-24 years), female sex, and as predictors of higher rates, alongside knowledge gaps on resistance that affect 70-80% of participants believing antibiotics treat viruses. Among health professionals in , a 2025 analysis found 25-35% , linked to workplace stress and perceived expertise, underscoring the need for professional to model appropriate use. These findings extend to broader trends, where in permissive markets correlates with elevated self-medication of non-antibiotics like analgesics, raising parallel concerns over risks without clear regulatory causation. Policy responses are evolving toward and access modulation, with the U.S. DEA's 2025 telemedicine rules expanding special registrations for remote prescribing of non-controlled drugs, potentially reducing self-medication for acute needs by formalizing virtual consultations while imposing verification requirements to curb misuse. In antibiotic hotspots, national campaigns in countries like and emphasize against informal sales, informed by 2024-2025 prevalence data showing 30-50% rates tied to lax oversight. Select regulators, including the FDA, continue approving switches to over-the-counter status for low-risk agents (e.g., certain antihistamines), aiming to channel self-medication toward safer options amid evidence of net in compliant populations, though global harmonization remains challenged by disparities.

References

  1. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.659503/full
  2. https://pubmed.ncbi.nlm.nih.gov/36193566/
  3. https://www.researchgate.net/publication/359680345_Global_WHO_Regional_and_Continental_Prevalence_of_Self-medication_from_2000_to_2018_A_Systematic_Review_and_Meta-analysis
  4. https://www.emro.who.int/emhj-volume-26-2020/volume-26-issue-7/prevalence-of-self-medication-in-university-students-systematic-review-and-meta-analysis.html
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC9312266/
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC9537481/
  7. https://www.emro.who.int/emhj-volume-17/issue-5/article8.html
  8. https://www.wma.net/policies-post/wma-statement-on-self-medication/
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC11347341/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC10747327/
  11. https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-025-06660-3
  12. https://pubmed.ncbi.nlm.nih.gov/9385000/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC1361129/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC4267359/
  15. https://link.springer.com/article/10.1023/B:JOEC.0000006440.57230.a9
  16. https://digitalcommons.usu.edu/cgi/viewcontent.cgi?article=1001&context=behave
  17. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0305219
  18. https://link.springer.com/chapter/10.1007/978-1-4899-1783-6_4
  19. https://www.frontiersin.org/news/2022/11/23/frontiers-ecology-evolution-great-bustards-self-medication
  20. https://www.livescience.com/10839-monarch-butterflies-medicate.html
  21. https://www.medicalnewstoday.com/articles/323556
  22. https://www.jstor.org/stable/41242932
  23. http://classics.mit.edu/Aristotle/history_anim.html
  24. https://www.pbs.org/newshour/science/how-humans-learned-to-self-medicate-with-certain-plants-by-observing-animals
  25. https://www.abdn.ac.uk/bestiary/
  26. http://www.tsmia.or.th/doc/20120202050323.pdf
  27. https://pubmed.ncbi.nlm.nih.gov/18344588/
  28. https://pdfs.semanticscholar.org/5b4a/0b1c9d1dd3fcc9ddbcbb812d42d3e0357c64.pdf
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC10439347/
  30. http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572014000400011
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC6717925/
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC10589874/
  33. https://sciety.org/articles/activity/10.21203/rs.3.rs-6685115/v1
  34. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15025-y
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC10069002/
  36. https://www.tandfonline.com/doi/full/10.1080/27707571.2023.2183564
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC6175215/
  38. https://pubmed.ncbi.nlm.nih.gov/3904487/
  39. https://www.psychiatrictimes.com/view/theory-self-medication-and-addiction
  40. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1107248
  41. https://www.niaaa.nih.gov/publications/cycle-alcohol-addiction
  42. https://psycnet.apa.org/record/2012-27770-002
  43. https://www.verywellmind.com/the-self-medication-theory-of-addiction-21933
  44. https://www.wjgnet.com/2220-3206/full/v5/i1/35.htm
  45. https://psychiatryonline.org/doi/10.1176/appi.ajp.2009.09030399
  46. https://www.ncbi.nlm.nih.gov/books/NBK562334/
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC4944485/
  48. https://academic.oup.com/emph/article/9/1/26/5998648
  49. https://www.dovepress.com/self-medication-practices-and-associated-factors-among-health-care-pro-peer-reviewed-fulltext-article-PPA
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC9936784/
  51. https://www.mdpi.com/2227-9032/13/15/1872
  52. https://www.mdpi.com/1660-4601/18/2/689
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC9704507/
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC11863577/
  55. https://www.mdpi.com/2079-6382/13/1/98
  56. https://www.sciencedirect.com/science/article/pii/S2772707624001152
  57. https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-13-252
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC7040277/
  59. https://aricjournal.biomedcentral.com/articles/10.1186/s13756-024-01466-6
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC6952762/
  61. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-015-2109-3
  62. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0293685
  63. https://www.sciencedirect.com/science/article/pii/S1526590018306412
  64. https://academic.oup.com/innovateage/article/7/10/igad103/7275223
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC9585802/
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC10955222/
  67. https://www.sciencedirect.com/science/article/pii/S2667276624000805
  68. https://www.mdpi.com/2227-9032/13/5/472
  69. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-015-1774-6
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC8196755/
  71. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1560299/full
  72. https://www.sciencedirect.com/science/article/pii/S2213398425001022
  73. https://www.palmerlakerecovery.com/programs/co-occurring-disorders/depression-anxiety-and-addiction/
  74. https://www.sciencedirect.com/science/article/abs/pii/S1078390399900538
  75. https://www.tandfonline.com/doi/abs/10.3109/00952999208992825
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC11874384/
  77. https://pmc.ncbi.nlm.nih.gov/articles/PMC9885035/
  78. https://www.tandfonline.com/doi/full/10.1080/13696998.2017.1390473
  79. https://aesgp.eu/content/uploads/2019/10/THE-ECONOMIC-AND-PUBLIC-HEALTH-VALUE-OF-SELF-MEDICATION.pdf
  80. https://www.frontier-economics.com/uk/en/news-and-insights/news/news-article-i10429-the-economic-impact-of-over-the-counter-medicines/
  81. https://www.fip.org/file/5111
  82. https://bmjpublichealth.bmj.com/content/2/2/e000542
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC12346020/
  84. https://pubmed.ncbi.nlm.nih.gov/25245937/
  85. https://jppres.com/jppres/pdf/vol11/jppres23.1671_11.6.1079.pdf
  86. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1184882/full
  87. https://www.bbcbonehealth.org/sites/bbc/files/documents/Adverse%2520Health%2520Events%2520Related%2520to%2520Self-Medication%2520Practices%2520Among%2520Elderly%2520-%2520a%2520Systematic%2520Review.pdf
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC5051244/
  89. https://onlinelibrary.wiley.com/doi/full/10.1002/pu.31009
  90. https://www.gatewayfoundation.org/blog/dangers-of-self-medication/
  91. https://www.ncbi.nlm.nih.gov/books/NBK554406/
  92. https://www.nami.org/about-mental-illness/treatments/mental-health-medications/types-of-medication/selective-serotonin-reuptake-inhibitors-ssris/
  93. https://www.mayoclinic.org/drugs-supplements/lorazepam-benzodiazepine-oral-route-injection-route/description/drg-20072296
  94. https://pmc.ncbi.nlm.nih.gov/articles/PMC11998457/
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC6563335/
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC7380783/
  97. https://www.amhsr.org/articles/a-systematic-review-of-the-literature-to-assess-selfmedication-practices-3711.html
  98. https://drsumaiya.com/post/the-hidden-dangers-of-self-medication-why-that-just-in-case-pill-could-be-harming-you/
  99. https://academic.oup.com/eurpub/article/25/3/444/2399187
  100. https://www.dovepress.com/self-medication-practice-and-associated-factors-among-health-professio-peer-reviewed-fulltext-article-IDR
  101. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
  102. https://www.cureus.com/articles/116613-self-medication-with-antibiotics-an-element-increasing-resistance
  103. https://jphe.amegroups.org/article/view/10217/html
  104. https://link.springer.com/article/10.1007/s44155-025-00225-1
  105. https://nealmuseum.wvu.edu/learn/2024/07/11/drug-regulation-in-the-united-states-part-i
  106. https://americanhistory.si.edu/collections/object-groups/balm-of-america-patent-medicine-collection/history
  107. https://pharmacy.wisc.edu/2019/12/05/tracking-the-evolution-of-u-s-drug-regulation/
  108. https://www.fda.gov/about-fda/histories-fda-regulated-products/history-drug-regulation
  109. https://www.visitthecapitol.gov/exhibitions/congress-and-progressive-era/pure-food-and-drug-act
  110. https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/part-i-1906-food-and-drugs-act-and-its-enforcement
  111. https://www.ncbi.nlm.nih.gov/books/NBK585046/
  112. https://www.fda.gov/about-fda/fda-history-exhibits/80-years-federal-food-drug-and-cosmetic-act
  113. https://www.aafp.org/pubs/afp/issues/1998/0501/p2209.html
  114. https://www.fda.gov/about-fda/histories-product-regulation/promoting-safe-effective-drugs-100-years
  115. https://pmc.ncbi.nlm.nih.gov/articles/PMC7245331/
  116. https://www.pharmaceutical-technology.com/sponsored/how-global-drug-regulations-are-evolving/
  117. https://www.who.int/publications/i/item/9789240052192
  118. https://pmc.ncbi.nlm.nih.gov/articles/PMC12370218/
  119. https://go.gale.com/ps/i.do?id=GALE%257CA64456597&sid=sitemap&v=1&it=r&p=EAIM&sw=w
  120. https://www.who.int/japan/news/detail-global/26-05-2025-who-unveils-new-guideline-to-improve-global-access-to-controlled-medicines
  121. https://pmc.ncbi.nlm.nih.gov/articles/PMC5415144/
  122. https://link.springer.com/article/10.1007/s10654-024-01153-1
  123. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1220984/full
  124. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X%2824%2900215-8/fulltext
  125. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2901694-5/fulltext
  126. https://pmc.ncbi.nlm.nih.gov/articles/PMC8863670/
  127. https://pubmed.ncbi.nlm.nih.gov/17940684/
  128. https://www.jahonline.org/article/S1054-139X(14)00276-6/fulltext
  129. https://www.researchgate.net/publication/45112726_Self-Medication_Among_Children_and_Adolescents
  130. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-12137-1
  131. https://www.mdpi.com/2079-6382/11/11/1583
  132. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189199
  133. https://pmc.ncbi.nlm.nih.gov/articles/PMC11857865/
  134. https://journalofethics.ama-assn.org/article/ama-code-medical-ethics-opinion-physicians-treating-family-members/2012-05
  135. https://www.goodrx.com/hcp-articles/providers/self-prescribing-laws-by-state
  136. https://www.sciencedirect.com/science/article/pii/S2667276622000166
  137. https://www.sciencedirect.com/science/article/abs/pii/S0033350618303883
  138. https://pmc.ncbi.nlm.nih.gov/articles/PMC10412933/
  139. https://www.sciencedirect.com/science/article/pii/S2405857222001449
  140. https://aricjournal.biomedcentral.com/articles/10.1186/s13756-017-0208-x
  141. https://www.sciencedirect.com/science/article/pii/S1876034123003623
  142. https://pmc.ncbi.nlm.nih.gov/articles/PMC11378505/
  143. https://www.sciencedirect.com/science/article/pii/S2049080122012420
  144. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.1041695/full
  145. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0259317
  146. https://jamanetwork.com/journals/jama-health-forum/fullarticle/2809985
  147. https://www.sciencedirect.com/science/article/pii/S2590170223000316
  148. https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2821%2900085-5/fulltext
  149. https://www.nature.com/articles/s41598-024-72440-w
  150. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-18984-y
  151. https://journals.sagepub.com/doi/10.1177/20420986221094141
  152. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1254817/full
  153. https://www.sciencedirect.com/science/article/pii/S2213398424001520
  154. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09876-y
  155. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access
  156. https://www.nature.com/articles/s41598-024-60931-9
  157. https://www.jccpractice.com/article/self-medication-and-public-perception-a-cross-sectional-study-on-awareness-and-practices-in-punjab-india-1010/
  158. https://www.bcbstx.com/provider/education/education/news/2024/10-17-2024-self-administered-drugs-moving-pharmacy-benefit
Add your contribution
Related Hubs
User Avatar
No comments yet.